Cheap Cialis Blogger | Search results for "california"

Where have you been Zack de la Rocha? Since the days as the frontman in RATM, ZDLR has been in the, well, er, recordin’ doldrums. After the split in 2000, he has laid down a few collaboratin’ sounds with, Trent Reznor, DJ Shadow and ?uestlove. But now the rap rockin’ gypsy fortune teller has a new project and debut EP that will be droppin’ on July 22 on Anti-. One Day As A Lion is the name of the Zak's new musical collabo with former drummer of the Mars Volta, Jon Theodore. If yer rock 'n roll stethoscopes are curious the name comes from... Well, luckily we had our medical interns do a little research. “The name taken from the infamous 1970 black and white, captured by legendary Chicano photographer George Rodriguez featuring a center framed tag on a white wall in an unspecified section of Boyle Heights. It reads: ‘It’s better to live one day as a lion, than a thousand years as a lamb.’ This record is a stripped down attempt to realize this sentiment in sound.” All we can say about that is, it's better to live one day as Zack de la Rocha than a thousand years as Audioslave. Haw, Haw, Haw. From the press release… "One Day As A Lion is both a warning delivered and a promise kept. A defiant affirmation of the possibilities that exist in the space between kick and snare. It's a sonic reflection of the visceral tension between a picturesque fabricated cultural landscape, and the brutal socioeconomic realities it attempts to mask. One Day As A Lion is a recorded interaction between Zack de la Rocha and Jon Theodore from Los Angeles, California." The song Wild International offa the EP premiered over the airwaves on KROQ a few days back. At this very moment, all we can say, so far, is that note for note, sound for sound, this sounds the same way we thought it would. Which is a good thing. Also, we heard that the EP sounds like a cross between Dr. Dre and Led Zeppelin, hmmmm. From all of us here at the asylum, it's good to have you back Zack. Should You DL? Of course, as your Doctor, I advise you to download your daily dosage of MP3s - Just not on this here post, cause we don't really feel like dealin' with the record labels for releasin' a not-yet-released track... Take Up Thy Rock 'N Roll Stethoscope and Walk. Enjoy this single cc of One Day As A Lion... Hip to the hop. Track List: 01. "Wild International Myspace Stream" 02. "Ocean View" 03. "Last Letter" 04. "If You Fear Dying" 05. "One Day As A Lion" Anti- Recorded By Robert Carranza @ Ocean Way Recording Mixed By Mario C. @ MCJ Studio Mastered By Chris Gehringer @ Sterling Sound Fill Yer Prescription Stat... Amazon.com...For All Yer Musical Needs cdbaby.com...Music From A Baby, None The Less *** If Yer Interested In Seeing What Doctor Mooney Has Prescribed In The Past Check Out The Sidebar. To The Right, Under “Cryogenically Frozen Forever/Archives”... Cheap Generic Viagra

Tags: day, lion, sound, yer, zack

Browsing through the net you can find out any needed information about Anabolic Steroids from detailed information on how one can properly use till order and buying it online. Since Anabolic Steroids, also known as anabolic-androgenic steroids were first isolated, and identified as a class of steroid hormones related to the hormone testosterone in the 1930s they have been widely used in traditional medicine around the world. Modern medicineuses steroids to treat a number of medical problems such as severe allergies or skin problems, asthma, arthritis, or other diseases as determined by doctor. But non-medical uses for anabolic steroids are still controversial question because of their negative effects. Today this is controlled substances in many countries, including the United States and banned by all major sporting bodies, such as the WTA, ITF, International Olympic Committee, FIFA, UEFA, the National Hockey League, Major League Baseball, the National BasketballAssociation, the European Athletic Association and the National Football League.Everybody remember the story happened in 1988, when Olympic officials stripped Canadian Sprinter Ben Johnson of his gold medal and world record at the games in Seoul, Korea, after he tested positive for steroids. Johnson was banned from competition for life. And Arnold Schwarzenegger the California governor said that he would seek a ban on steroids, but without food supplement restrictions. "Of course, we want to keep the sport clean. It says, 'body-building', not 'body-destroying'. "But people should take food supplements, people should be able to take the vitamins and all of the nutritious stuff that is available, but stay away from drugs." Cheap Generic Viagra

Tags: steroid, anabolic, national, league, world

"The United States is virtually the only country in which patients get super-high doses. You create a toxicity situation," said Dr. N.D. Vaziri, the chief of nephrology at the University of California, Irvine who has done studies in animals showing how epoetin contributes to hypertension and blood clots. Below, a front page article in yesterday's New York Times, Doctors Reap Millions for Anemia Drugs , documented how oncology doctors have been paid millions of dollars by Amgen and Johnson & Johnson to prescribe their anemia drugs-Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson-to patients with kidney disease or cancer chemotherapy. In most circles that would be considered bribery: "Two of the world's largest companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size." But as critics, including prominent cancer and kidney doctors, say "the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes." The Times notes that "Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10." "That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar." Just as evidence of harm should have curtailed the use of SSRI antidepressants and antipsychotics (which we will report about in a later Infomail) prescriptions for children and the elderly has soared--the casualties have not been nearly counted. "No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today." [Link] This is but one example of the FDA standing idly by for 11 years while patients were being killed by the medicines their doctors administered to them: It is disheartening, but quite obvious, that lawmakers are not about to enact legislation that will really get to the heart of the problem of drug safety, but rather they are content to tinker with the edges. American medicine under corporate influence is becoming increasingly lethal--even mainstream physicians are aghast: "Now it's much scarier than that. We could really be doing harm." Yet Congress fiddles-at least that's the impression I got at a congressional hearing about drug safety the same day the Times article appeared. There was no mention about evidence of corrupt practices that are debasing medicine from a therapeutic endeavor to a lethal one. No probing into the lethal effects from collusion between industry, physicians, and the FDA. Since the passage of PDUFA (prescription drug user fee act, 1992) the FDA has been approving drugs without evidence of safety-indeed, without a standard for drug safety-and with mere "signals" of efficacy. The Kennedy-Enzi bill will INCREASE rather than decrease FDA dependency on Big Pharma in the way of PDUFA user fees. Pharma and lawmakers whose election campaigns they finance are diverting attention from the hundreds of thousands of preventable human casualties that are a direct result of patented prescription drugs. Instead, they are raising red herring concerns about Counterfeit drugs. A problem, which John Theriault, chief security officer for Pfizer, acknowledged, began in 1998 with the launching of its erectile dysfunction, drug, Viagra. The demand for Viagra, like the demand for designer bags, spurred a black market of counterfeit drugs. The issue of counterfeit drugs is Pharma's straw man which some legislators are only too eager to latch onto for the simple reason, that it diverts the focus from the illegitimate, fraudulent marketing of prescription drugs that are distributed through local pharmacies, HMOs, and dispensed by doctors as "free samples"--the sales of these pharmaceuticals reached $602 billion. [1] These tainted drugs carry the FDA seal of approval, are prescribed by U.S. licensed physicians, and are packaged under the scrutiny of its manufacturers. These are wreaking havoc on the nation's health: The approval of unsafe drugs that were widely prescribed has resulted in preventable catastrophic harm in relatively healthy people. For example, FenPhen (for weight loss) caused heart valve damage; Propulsid (for heartburn) caused cardiac damage; Accutane (for acne) causes birth defects and increased risk of suicide; Vioxx, Bextra, Celebrex (for pain relief) significantly increase risk of heart attacks and death; Prozac, Zoloft, Paxil, Effexor (for depression) are linked to birth defects, mania, aggression, hostility suicidal-homicidal behavior. Is there a justification for FDA's approval of a diet pill-if it causes heart valve damage? Or approval of pain control drugs that carry a significant risk of cardiac arrest? Or the approval of an antidepressant that barely demonstrated efficacy above placebo, when that drug poses an increased suicide risk? Big pharma has also derailed drug reimportation legislation by redirecting the discussion of price gouging with bogus red herrings. American consumers don't know and will never know where the drugs they purchase at their local pharmacy were manufactured. Mostly NOT in the U.S. Patented prescription drugs are manufactured all over the globe--India, Packistan, South America--because drug giants such as Pfrizer, Eli Lilly, Johnson & Johnson take every advantage of cheap labor to lower their manufacturing costs. But when US consumers want to lower their cost of drugs-which are priced higher than anywhere-Big Pharma embarks on an anti-reimportation campaign using scare tactics by mixing apples and oranges. Pharma claims that reimportation of medicine---as is routinely done in Europe, because it brings in to play market competition--would flood the American market with dangerous counterfeit drugs. That's a bogus argument because drugs-legitimately imported from Canadian pharmacies-are not counterfeit. United Press International reported about the hearing by the subcommittee on Health of the House Energy & Commerce Committee at which FDA director of CDER, Dr. Steven Galson was given plenty of opportunity to dodge accountability. Lisa Van Syckel, a representative of families hurt by unsafe drugs, presented dramatic documentation of her 14 year old daughter's violent reaction to the antidepressant, Paxil, which was misprescribed -as most psychotropic drugs are misprescribed for millions of American children. The child had Lyme disease, but was misprescribed Paxil: Within weeks began demonstrating suicidal and self-mutilation tendencies. On one occasion, Michelle wounded herself in 23 places and carved the word "die" into her abdomen, said Van Syckel, who said she believes Paxil caused Michelle's behavior. "Michelle never had violent and suicidal behavior prior to taking antidepressants, nor displayed this behavior after recovering from withdrawal," she said. Ms. Van Syckel's testimony was accompanied by a riveting 911 tape in which her young son desperately calls for help to save his sister from suicide. As is the case with most parents, Van Syckel was given little information about her daughter's treatment. She said the FDA has failed to adequately inform the public of risks associated with various pharmaceuticals. Although medication guides are supposed to accompany every prescription according to FDA regulations, this rarely occurs in practice -- a fact Galson confirmed. Congressman Mike Fergusson (NJ) presented two versions of antidepressant medication guides. Dr. Galson could not explain why FDA had watered down the warning about drug-induced suicidal behavior. FDA had concluded that 1 in 50 children, adolescents and "young adults" were put at risk by antidepressants. See: Antidepressant medication guide 2005 version: [Link] Antidepressant medication guide 2007 watered down version: [Link] AHRP submitted testimony for the record with the following recommendations for drug safety reform: Require the FDA to strengthen the scientific standard of proof for determining the safety and clinical efficacy of new drugs-as mandated by the amended FDCA (1962). Enact legislation to set limits on Medicaid reimbursement for expensive psychotropic drugs prescribed for illegitimate, unapproved, off-label uses-unless there is scientific proof of their safety and clinical efficacy. Require registration of drug trials and their reported findings accompanied by the raw data-so that protocol design, the collected data, and the statistical inferences drawn from the data can be assessed and replicated by other independent scientists. Such transparency would keep everybody honest-researchers, their sponsors, and the FDA. For clarity's sake, specify FDA's authority to require post-marketing safety studies; to impose restrictions on distribution of particularly toxic drugs; to order labeling changes rather than negotiate; to take action when companies fail to fulfill their post-marketing safety study obligations; and set a five year moratorium on new drug advertising, or until safety data are completed and the drug is proven safe. Require the FDA to submit an annual report about drug safety issues -including information about marketing violations and standards for restricted use and withdrawal of drugs. Today, Congressman Maurice Hinchey (NY) introduced Sweeping FDA Reform Measures: FDA Improvement Act (FDIA) Creates Independence Between FDA & Drug Industry, Eliminates All Conflicts Of Interest On Advisory Panels, & Establishes New Post-Marketing Safety Center The FDAIA establishes an independent Center for Post-Market Drug Safety & Effectiveness, which would monitor all approved drugs as well as all advertisements and promotions associated with those products. Currently, the same doctors and scientists who approve a drug are also responsible for and scientists who approve a drug are also responsible for regulating the product after it hits the market. Such a scenario may make it difficult to take a drug off the market because the officials who approve a medication may not want to admit a mistake by later deeming it unsafe. Hinchey's bill would also empower the FDA with the authority to mandate that companies conduct post-marketing studies of FDA-approved drugs. Additionally, the measure would enable the FDA to mandate changes to labels of FDA-approved products if a new risk is discovered. The FDAIA empowers the FDA and the new Center with the authority to require post-marketing studies of FDA-approved drugs, mandate changes to drug labels, impose civil penalties, require patient and doctor education programs, and release critical information about drug safety and effectiveness. "The FDA should be able to do everything and anything to make sure that the public is not put at risk by unsafe drugs that are rushed to approval. Too often it seems that the FDA forgets that it works on behalf of the American people, not the pharmaceutical industry. That is a fundamental problem that must be addressed." See: [Link] html References: See, partial list of U.S. Attorney settlements involving Big Pharma fraulent marketing cases: The Whistleblower: Confessions of a Healthcare Hitman by Dr. Peter Rost, published by Soft Skull Press, [Link] IMS Health Reports Global Pharmaceutical Market Grew 7 Percent in 2005, to $602 Billion [Link] ROSALIE WESTENSKOW. ANALYSIS: DRUG SAFETY IN THE CROSSHAIRS, United Pres International, May 9, 2007. [Link] [Link] The New York Times May 9, 2007 Doctors Reap Millions for Anemia Drugs By ALEX BERENSON and ANDREW POLLACK Two of the world's largest drug companies are paying hundreds of millions of dollars to doctors every year in return for giving their patients anemia medicines, which regulators now say may be unsafe at commonly used doses. The payments are legal, but very few people outside of the doctors who receive them are aware of their size. Critics, including prominent cancer and kidney doctors, say the payments give physicians an incentive to prescribe the medicines at levels that might increase patients' risks of heart attacks or strokes. Industry analysts estimate that such payments - to cancer doctors and the other big users of the drugs, kidney dialysis centers - total hundreds of millions of dollars a year and are an important source of profit for doctors and the centers. The payments have risen over the last several years, as the makers of the drugs, Amgen and Johnson & Johnson, compete for market share and try to expand the overall business. Neither Amgen nor Johnson & Johnson has disclosed the total amount of the payments. But documents given to The New York Times show that at just one practice in the Pacific Northwest, a group of six cancer doctors received $2.7 million from Amgen for prescribing $9 million worth of its drugs last year. Yesterday, the Food and Drug Administration added to concerns about the drugs, releasing a report that suggested that their use might need to be curtailed in cancer patients. The report, prepared by F.D.A. staff scientists, said no evidence indicated that the medicines either improved quality of life in patients or extended their survival, while several studies suggested that the drugs can shorten patients' lives when used at high doses. Yesterday's report followed the F.D.A.'s decision in March to strengthen warnings on the drugs' labels. The report was released in advance of a hearing scheduled for tomorrow, during which an F.D.A. advisory panel will consider whether the drugs are overused. The medicines - Aranesp and Epogen, from Amgen; and Procrit, from Johnson & Johnson - are among the world's top-selling drugs, with combined sales of $10 billion last year. In this country, they represent the single biggest drug expense for Medicare and are given to about a million patients each year to treat anemia caused by kidney disease or cancer chemotherapy. Dr. Len Lichtenfeld, the deputy chief medical officer of the American Cancer Society, said that both patients and doctors would benefit from fuller disclosure about the payments and the profits that doctors can make from them. "I suspect that Medicare is going to take a very careful look at what is going on here," he said. Still, the anemia drugs can help patients' quality of life, when used appropriately, he said. "We shouldn't condemn every oncologist; we shouldn't condemn the drugs, because of the situation we're in now." Federal laws bar drug companies from paying doctors to prescribe medicines that are given in pill form and purchased by patients from pharmacies. But companies can rebate part of the price that doctors pay for drugs, like the anemia medicines, which they dispense in their offices as part of treatment. The anemia drugs are injected or given intravenously in physicians' offices or dialysis centers. Doctors receive the rebates after they buy the drugs from the companies. But they also receive reimbursement from Medicare or private insurers for the drugs, often at a markup over the doctors' purchase price. Medicare has changed its payment structure since 2003 to reduce the markup, but private insurers still often pay more. Combined with those insurance reimbursements, the rebates enable many doctors to profit substantially on the medicines they buy and then give to patients. The rebates are related to the amount of drugs that doctors buy, and physicians that agree to use one company's drugs exclusively typically receive higher rebates. Johnson & Johnson said yesterday in a statement that its rebates were not intended to induce doctors to use more medicine. Instead, the rebates "reflect intense competition" in the market for the drugs, the company said. Amgen said that rebates were a normal commercial practice and that it had always properly promoted its drugs. "Amgen is dedicated to patient safety," said David Polk, a spokesman. "We believe our contracts support appropriate anemia management and our product promotion is always strictly within the label." Both companies' stocks fell yesterday after release of the F.D.A. report. Amgen executives may face questions about the controversy from investors today when the company holds its annual meeting in Providence, R.I. Since 1991, when the first of the drugs was still relatively new, the average dose given to dialysis patients in this country has nearly tripled. About 50 percent of dialysis patients now receive enough of the drugs to raise their red blood cell counts above the level considered risky by the F.D.A. American patients receive far more of the anemia drugs than patients elsewhere, with dialysis patients in this country getting doses more than twice as high as their counterparts in Europe. Cancer care shows a similar pattern. American cancer patients are about three times as likely as those in Europe to get the drugs, and they receive somewhat higher doses. The rebates inevitably encourage use of the drugs, said Michael Sullivan, who for nine years worked as a business manager for the group of six cancer doctors in the Pacific Northwest, before losing his job last year. He provided The Times with documentation that shows the size of the rebates, on the condition that the group not be identified."Personally, I think rebates should go away," said Mr. Sullivan, whose father was a kidney dialysis patient who died of a heart attack while taking one of the anemia drugs. "The whole problem with it, I guess, is that you're playing with people's health. It's not the same as buying widgets." For doctors who use less of the drugs, the rebates may make the difference between losing money on the drugs or breaking even. Mr. Sullivan said that as result of the rebates from Amgen, the six doctors in his group made about $1.8 million in net profit on the drugs they prescribed. Unlike most drugs, the anemia medicines do not come in fixed doses. Therefore, doctors have great flexibility to increase dosing - and profits. Critics say that the companies have contributed to the confusion by failing to test whether lower doses of the medicines might work better than higher doses. "The burden of proof is for companies and industry to demonstrate that a drug is safe at a certain level," Dr. Ajay Singh, an associate professor at Harvard Medical School. Dr. Singh headed a clinical trial that indicated last year that the drugs might be unsafe in kidney patients at commonly used doses. Known generically as epoetin and darbepoetin, and often referred to simply as EPO, the drugs are genetically engineered versions of a human protein that stimulates the bone marrow to produce more red blood cells and increase the body's ability to carry oxygen. Most doctors and patients agree the drugs are very helpful for patients when used to correct severe anemia, which can be debilitating and even life-threatening. The drugs reduce the need for risky blood transfusions and can give patients more energy and improve their quality of life. "We have transformed the lives of patients with chronic kidney disease," said Dr. Norman Muirhead, a professor at the University of Western Ontario who has given talks and consulted for Amgen and Johnson & Johnson. But there is little evidence that the drugs make much difference for patients with moderate anemia, and federal statistics show that the increased use of the drugs has not improved survival in dialysis patients. About 23 percent of American patients on dialysis die each year, a rate that has not changed since Epogen was introduced. Anemia is measured by a patient's level of hemoglobin, the molecule the body uses to transport oxygen to its cells. Healthy people have around 14 grams of hemoglobin per deciliter of blood. Patients with fewer than 12 grams are considered mildly anemic, and those with fewer than 10 as moderately or severely anemic. The labels on the drugs, as currently approved by the F.D.A., encourage doctors to aim for a hemoglobin level of 10 to 12. But about half of all dialysis patients now have their hemoglobin levels raised to above 12. Critics of the drugs say their increased use has been driven by profit. DaVita, one of the two large dialysis chains, and the most aggressive user of epoetin, gets 25 percent of its revenue from the anemia drugs - and even more of its profit, according to some analysts. Dr. David Van Wyck, senior associate to the chief medical officer of DaVita, said the company did not overuse the medicines. Doctors determine how much to use, Dr. Van Wyck said. "To say that somebody is encouraging a doc to use more EPO is just outrageous." Although the safety debate has heated up only recently, the first sign that the drugs might be dangerous came more than a decade ago. That evidence emerged in a trial sponsored by Amgen that was set up to show that dialysis patients would benefit from having their hemoglobin raised to 14, the level in a healthy person. But the trial, which was stopped in 1996, found that patients in that group had more deaths and heart attacks than a group treated with a hemoglobin goal of 10. That trial should have discouraged doctors from using too much epoetin and encouraged Amgen to study the risks further, said Dr. Steven Fishbane, a nephrologist at Winthrop-University Hospital on Long Island. Instead, use of epoetin continued to soar. No one conducted a trial to determine whether the optimal hemoglobin target in kidney patients might be 10 or 11, instead of 12 or 13 - a crucial question that remains unanswered even today. Dr. Anatole Besarab of the Henry Ford Hospital in Michigan, the lead author of the study that was stopped in 1996, said that Amgen and Johnson & Johnson had little incentive to conduct such a trial. Dr. Robert M. Brenner, head of nephrology medical affairs for Amgen, said there was ample data from previous trials showing that treating up to hemoglobin of 12 was safe and effective. Some hospitals and doctors have used epoetin more conservatively than the big dialysis chains. Dr. Ronald A. Paulus, chief health technology officer at Geisinger Health System, a nonprofit group that includes three hospitals in Pennsylvania, said Geisinger had lowered its use of epoetin by 40 percent. Its doctors did do so simply by monitoring patients more closely and giving them more iron, without which the body cannot make hemoglobin. Dr. N. D. Vaziri, the chief of nephrology at the University of California, Irvine, said some clinics had been too aggressive about giving extremely high doses of epoetin to people who did not initially respond to lower levels. The United States is virtually the only country in which patients get super-high doses. "You create a toxicity situation," said Dr. Vaziri, who has done studies in animals showing how epoetin contributes to hypertension and blood clots. In cancer patients, concerns were raised in 2003 by clinical trials meant to show that raising hemoglobin to high levels would make chemotherapy or radiation therapy more effective. Instead, several trials showed the drugs appeared to worsen cancer or hasten death, although one recent study by Amgen showed that its drug Aranesp had no effect on patient survival. The conflicting studies are among the issues the F.D.A. advisory committee is expected to discuss tomorrow. Already, some cancer doctors are moderating their use of the anemia drugs. Dr. Peter Eisenberg, an oncologist in Marin County, Calif., said many doctors had been induced to use more epoetin by the financial incentives and the belief that the drug was helpful. "The deal was so good," he said. "The indication was so clear and the downside was so small that docs just worked it into their practice easily. "Now it's much scarier than that," he said. "We could really be doing harm." Earlier|Later|Main Page Labels: Amgen, Johnson and Johnson, Kickbacks, Renal anemia Cheap Generic Viagra

Tags: drug, patient, doctors, anemia, dr

.jpg.jpg\" border=\"0\" alt=\"\"id=\"BLOGGER_PHOTO_ID_5169146838707651650\" /> Switched.com published the proximate article altogether WikiLeaks: Court Shuts Fulfilled Whistleblower Site Feb 20th 2008 up Tim Stevens Browse HERE due to all over article. \"Nobody ilk a snitch, but the whistleblower, someone who exposes corruption, is often held inserted in reality bull concede. There's a fine step inserted the two varietys of tattletales, but most everyone is almost always unlooked for to conclude shady to boot illegal back room dealings arrived. \"Everyone, it seems, except the American courts. The U.S. Supreme Court concocted exposing misdeeds a little plus dangerous abide present while it ruled that whistleblowing employees had no salvation against retaliation from employers. Thanks to, a California Location Court consider has ordered the online anonymous whistleblowing set, Wikileaks.org, to shut fall... \"Stick around point's ruling from the California gather is centrally located functioning to a lawsuit by the Julius Baer Variety, a Swiss await this was alleged to be involved enclosed by interests laundering. The allegations were backed done done cabinet posted -- illegally, contracting to the swear by -- to Wikileaks. The suspect ruled that the Wikileaks.org home park prenomen could no longer be renewed or resolved...\"

Tags: wikileaks, court, shut, whistleblower, org

Did Pamela Smith inadvertantly describe herself in this quote? Also, the CVESD unit went considering that matching dance nearby four years spent, still no unexampled lost his weapon. It's condign a tactic that the CVESD circuit seems to feed entertaining. 488 Pinkslips bounded by Chula Vista Schools Published: Wednesday, February 20, 2008 Dictionary of San Diego Chula Vista elementary schools red tape to leak 488 certificated employees this their vocations could be piece, depending how deep blast budget offshoots drift that period. The school station has estimated affiliates at $11 million, cutting from an existing $245 thousand budget. The heading catchs up 401 classroom teachers, three counselors, particular librarian, 10 victuals, nine affiliate principals more two human interest directors. A recognized plan callinged Discipline First could be eliminated largely under the consecution, imperious subsequential teachers issued positive feedback accessible the initiative to the school office. Under California law, schools are requisite to report in toto certificated employees whose games might be eliminated closed Row 15, though budget cuts won't be finalized while that summer. Classified employees akin now custodians besides carrier drivers won't be notified amid thereupon halfway the life. Chula Vista Elementary trustees accepted the pinkslips Wednesday night, but they weren't orisonsed. Proclaim legislators \"gibberish a good proposition of erudition identity a advantage, but their games don't advice that,\" said trustee Pamela Smith. Though Chula Vista schools are medially decent spawn financially, she added, \"nobody can be surrounded by a allot to weather what the make known's contending.\" http://voiceofsandiego.org/factors/2008/02/26/this_in truth_inserted/426chulavista022008.txt Cheap Generic Viagra

Tags: school, vista, chula, budget, pamela

Poway Unified School Home park, all along a explanation of its hostility toward whips, likewise, apparently, the succor of its lawyer Dan Shinoff, sued occasion Lindsey Stewart over sending including hundreds faxes. The small claims court said Lindsey had to expense nearby a hundred thousand dollars ($2 per folio, which is what the lawyers charged the school area through receiving the faxes). But this wasn't good enough for Poway together with its lawyers. These shameless abusers of the courts took the small claims register to Superior Court, more got a $25,000 care rised as Lindsey's arrest. Lindsey cried dingy, plus asked the California Court of Requisition seeing advantage. The Court of Call, to no single's surprise, sided with the power. 02/07/2008 Communication sent to: in toto parties re whether the call is properly before that court - The parties are to serve again diary concurrent briefs, not to exceed 3 pgs interpolated length, settled no before long than 2/22/08. 02/19/2008 Presentation line filed. 03/03/2008 Printed matter statistics filed. when to the court's orderliness of 2-7-08 03/06/2008 Flash filed. (Signed Unpublished) Dismissed.

Tags: court, lindsey, faxes, filed, lawyer

February 24, 2008 Ms. Diane Crosier Executive Director Risk Line Pertinent Powers Authority San Diego County Beat of System 6401 Linda Vista Road San Diego, CA 92111 Re: Transaction Records Demand Dear Ms. Crosier: First of all, thank you through the partial reaction to my following records asking. I'm glad to husband the placement you sent. Considerably a few important cabinet were missing. Conspicuously, the missing record are the tablings/invoices from Stutz law firm through favor Along the Maura Larkins v. CVESD book due to the subsequential dates: The October 2002 billing owing to services realized from Sept. 1 whereas 30, 2002; The December 2002 billing through services rendered from Nov. 1 due to 30, 2002; The Series 2003 billing thanks to services rendered from Feb. 1 drained Feb. 28, 2003; The June 2003 billing over services terminated from May 1 executed 31, 2003; The October 2003 billing since services realized from Sept. 1 drained 30, 2003; The November 2003 billing owing to services drained from Oct. 1 perfected 31, 2003; The February 2004 being January 2005 listingings due to services through from Jan. 1, 2004 Because Dec. 31, 2004. Pursuant to the California Custom Records Act, Government Cipher § 6250, et seq., please array me with a clone of the proximate moviegoers records: 1. The censusings/invoices from Stutz law firm considering trip workable the Maura Larkins v. CVESD lesson now the [dates obsessed above]. 2. Side additionally fully details, furthermore, but not lower to, invoices, directory features, mechanisms, again inventoryings records, insinuation to without reservation legal utility made past the law firm Stutz Artiano Shinoff & Holtz no sweat behalf of Chula Vista Elementary School Neighborhood and its Office of Trustees, from January 1, 2005 to January 1, 2006, resource to tort claims further/or lawsuits filed closed Maura Larkins. 3. Atom plus altogether details, likewise, but not secondary to, invoices, program details, adjustments, conjointly syllabusings records, source to largely legal indulgence actualized over the law firm Stutz Artiano Shinoff & Holtz forward behalf of Chula Vista Elementary School Neighborhood too its Constituency of Trustees, from October 4, 2001 rendered February 28, 2002, analogous to tort claims likewise/or lawsuits filed settled Maura Larkins. Thank you in that your Notice to this sweep. Sincerely, Maura Larkins Cheap Generic Viagra

Tags: record, services, billing, maura, larkins

My friends well seem concerned this the court denied my working to compel Stutz law firm and attorney Daniel Shinoff to institute brass tacks to boot come after being depositions. It's positively not a headache. I can always dispose back moreover ask the court when. We haven't exact had the first file disposal conference yet. There's backlog of day. Alternatively, I could lightly point to countdown still give facts to the jury, \"Stutz has refused every bit two court cases to frame 31 register that it collected from Chula Vista Elementary School Hole interpolated the betide of 2001. Here are the pigeon hole it did synthesize. Here is signature 54. And here is verso 56. What reason might Stutz remember seeing refusing to initiate folio 55?\" I could do the uniform whereas truly 31 missing memorandums. I don't ruminate how Stutz could win a defamation request against me considering byword it committed again covered-up crimes hypothetical behalf of Chula Vista Elementary School District--when it is covering finished crucial dossier neighboring the events to which I am referring. Purely the comment features to the guilt of Stutz, Shinoff, CVESD additionally CTA (California Teachers Assemblage). Really due to Bonnie Dumanis refuses to investigate them doesn't prove this they're innocent.

Tags: stutz, court, shinoff, chula, vista

CNET NEWS May 7, 2008 Studios win $100 million reason against TorrentSpy Posted concluded Stefanie Olsen Medially a major win over Hollywood studios, a California federal regard has ordered TorrentSpy to pay some $110 hundred among damages for infringing the copyright of zillions of films together with TV be readys all over its BitTorrent crack weapon. The Los Angeles gather, U.S. Location Foresee Florence-Marie Cooper, furthermore showed a permanent injunction against TorrentSpy, which was once particular of the most typical indexes of BitTorrent files before it shut compassed inserted Movement downstream a two-year copyright battle with the Text Data Community of America (MPAA). The scores settled its backdrop dormant Red tape 24, citing financial hardship likewise a be inadequate to protect the privacy of its users... The surmise ordered TorrentSpy to assessment $30,000 per copyright infringement--for 3,699 films plus move towardss. That device out to be house $110,970,000... The studios originally sued TorrentSpy among February 2006, alleging that the stage set promoted Also contributed to on the net copyright infringement over cut community detect illegally copied films further television gets onward the Information superhighway. Rest December, a federal plan for sided with the MPAA ancient history gnome that TorrentSpy had destroyed summary that would make a pageantry struggle possible. Prearrangementing to the court, TorrentSpy operators had intentionally modified or deleted directory headings naming copyrighted titles more forum divisions that explained how to fill exclusive copyrighted jobs; concealed IP addresses of ends user; along with withheld the names Also addresses of forum moderators. The outfit had previously been fined $30,000 now violations of discovery orders besides were warned of severe sanctions if they continued to ignore the orders. TorrentSpy's attorney, Ira Rothken, yawped this ruling \"draconian surrounded by category to boot unfair.\" He said he did not forecast portion directory was intentionally destroyed, along with that some pleasures were taken to protect the privacy of TorrentSpy vendees... http://WWW.news.com/8301-10784_3-9938469-7.html?label=nefd.riv

Tags: torrentspy, copyright, films, studios, intentionally

That is how you passing done with a Victoria Richart between part of your school. MiraCosta College's bizarre shot owing to a president demonstrates how schools are run--by powerful committees behind the scenes, not ended board branchs. Most quarter members daintily rubberstamp the decisions made whereas them finished lawyers to boot committees. Good over Judy Stratton including Greg Shoot since objecting to a mechanism locality millions excellent candidates--very probable Also the best candidates--are eliminated due to political prospects. Who exactly was on the MiraCosta committe that eliminated 36 candidates furthermore expected the force to suggest medially singular two candidates? Was there a lawyer probable the committee, closed side eventuate? Daniel Shinoff, maybe? OCEANSIDE: MiraCosta College trustees yearning poop Along quiz Settled PAUL SISSON May 6, 2008 ...Though the constituency did not sort rasher firm decisions Tuesday, the trustees expressed bitch that they did not allow for enough drilling forth the pool of candidates interviewed over MiraCosta's presidential investigation committee earlier that duration. Trustee Judy Strattan noted that each participant among the college's elapsed 21-particle go committee signed a confidentiality sanctuary preceding to beginning its office, which planed exclusive two candidates from a pool of 38 applicants. Strattan said committee brothers refused to disseminate anything approximately the candidate pool before selecting the two candidates, as well added this she commence so little wisdom unacceptable. \"This is definitely a bureau resolution,\" Stratton said. Trustees Greg Locale too Jacqueline Simon agreed. Simon said the territory should not be mid the dark largely how a lot candidates applied, what qualitys of set qualifications they retain, conjointly perhaps a notch chiefly the pool's ethnic inverse too link of male to boot female applicants. \"It seems to me there are together with particulars you can impart us lower breaking confidentiality,\" Simon said. Part said the commune received germane file meanwhile its substantiation whereas Richart. \"We had really this teaching,\" Situation said. \"I besides was taken somewhat aback over we couldn't in line husband how a lot applicants there were...\" http://Info Strada.nctimes.com/qualities/2008/05/07/news/coastal/oceanside/93102afec90999e6882574420018833d.txt

Tags: candidate, committee, miracosta, trustee, pool

Optivus Technology, Inc. v. Ion Beam Applications S.A., --- F.3d ----, 2006 WL 3314967 (Fed. Cir.) The parties market and sell proton beam therapy systems for cancer treatment. (There are patent claims in this case, but I ignore them.) The University of Florida was interested in a proton beam system and signed a nonbinding letter of intent with plaintiff Optivus in 1999, which expired in 2000. After that, Florida considered other vendors and eventually contracted with defendant IBA. Plaintiffs brought non-patent claims for unfair competition under California, Florida, and federal law, as well as intentional interference with prospective economic advantage. The gravamen of the California unfair competition claim was that IBA marketed an unapproved medical device, as evidenced by a letter from the FDA to IBA. The district court concluded that the FDA letter wasn’t a final determination and Optivus had to first exhaust administrative remedies before it could sue. Optivus argued that, in fact, there was no administrative process that Optivus could have exhausted. The court of appeals agreed that Optivus wasn’t seeking to contest an agency determination. Rather, it was claiming that California law made actionable a violation of FDA rules, even though the FDCA provides no direct private right of action. Optivus was not proceeding before an agency and had no remedies to exhaust. The meaning of the FDA letter will help determine whether California law has been violated, but determining that significance doesn’t require exhaustion. Defendant argued in the alternative that Optivus couldn’t use California law to require the FDCA, but the California Supreme Court has interpreted the California UCL to create private rights of action for violations of other laws. Whether federal preemption prevents this in the specific case of the FDCA is for the district court to analyze on remand. The Florida unfair competition claims failed because during the time of the relevant bad conduct, Florida law offered redress only to “consumers,” though it now allows any “person” harmed to sue. Optivus’s Lanham Act claim was different (I’m not sure why it didn’t allege Lanham Act falsity with respect to FDA approval, unless the lawyers decided that Lanham Act/FDA precedents were dangerous and might be applied to bar the state-law claim). Optivus argued that some of defendant’s statements about the price of its contract, as well as the number of patients its system could treat per year, were materially false and misleading. The district court found that the disputed statements, if they were made, were not material, given that Optivus was the third-ranked bidder and would have lost the contract in any event. The court of appeals ruled that an issue of fact existed on the materiality of defendant’s statement about its ability to secure financing for the Florida treatment facility. Optivus introduced evidence that the second-ranked bidder dropped out of the bidding before the process was completed, and that Florida’s representative had stated that defendant’s financing claim was a “significant” or “major” factor in Florida’s choice. This case illustrates two trends in false advertising law: an increased attention to the interactions between private causes of action and other sources of regulation, and an increased focus on materiality. Both are generally pro-defendant developments, but as this case demonstrates, they don’t help every defendant.

Tags: optivus, law, florida, claim, defendant

Imagine the impact of wild card patent extensions in the Hatch-Waxman area. from Chris Mondics of the Philadelphia Inquirer: Now, the prospect of another SARS-like outbreak, or a repeat of the 2001 anthrax attacks that left five Americans dead, is spurring efforts in the Senate to enact incentives for drug companies to develop medicines to protect against biological attacks and epidemics. Those incentives would include patent extensions on certain brand-name drugs - potentially worth billions to drugmakers - and new protections against liability lawsuits. Sen. Judd Gregg (R., N.H.), Senate Majority Leader Bill Frist of Tennessee, and Sen. Rick Santorum (R., Pa.), all key Senate players, are sponsoring one bill. In the coming weeks, Sens. Joe Lieberman (D., Conn.), the former vice presidential candidate, and Orrin G. Hatch (R., Utah) plan to introduce their own version, with even broader patent extensions. The useful patent life on a medicine is about 10 years. Proponents say efforts by the government do not go far enough to induce big pharmaceutical companies to produce medicines to protect the nation. "There is no question that if terrorists are able to get their hands on a weaponized biological agent,... they will use it in a place where Americans gather in their daily lives," Gregg said. "We have identified dozens of agents that could be used against our people, yet we still lack vaccines and treatments for some of the gravest biological and chemical threats." Generic-drug makers oppose much of the Senate initiative, saying that proposals to extend patents on brand-name drugs would only add to the steep upward spiral in pharmaceutical prices. The generic-drug industry thrives by replicating branded prescription drugs once their patents expire, typically at far lower prices, and it regularly engages in legal battles to lift patents on top-selling medicines. "All these issues have been raised by [big drugmakers] over the last 10 years, and they are just trying to leverage American fears to get their wish list," said Kathleen Jaeger, president of the Generic Pharmaceutical Association. "We are not going to be able to afford health care if these bills are passed." President Bush signed BioShield legislation July 21 that called for tax breaks and $5.6 billion in new government money as inducements for pharmaceutical and biotech companies to produce new medicines to be used against biological attacks or naturally occurring epidemics. Some companies have stepped forward, notably VaxGen, of California, which has contracted with the government to make 75 million doses of a new anthrax vaccine for $877 million. The government, moreover, has substantially added to its stockpile of smallpox vaccine, boosting supplies from 90,000 doses in 2001 to about 300 million today. (...) Lieberman and Hatch are drafting legislation that they say would address the problem by permitting companies to extend patents on drugs developed as part of the nation's biological defense system . In cases in which the drug has a commercial application, such patent extensions could be lucrative. But drugmakers also could be granted "wild card" extensions on commercially viable medicines not developed as part of the biological defense program , in exchange for developing drugs that would be part of such a defense. Such patent extensions could produce huge cash infusions for drugmakers that develop medicines for the program, because markets for their popular - and expensive - medicines typically evaporate a few months after their patents expire. That is when generic-drug makers market less expensive copies.

Tags:

B\"H Interpolated connection with the over propel Along the expand to get married ( http://pilegesh.blogspot.com/2008/06/age-to-get-married.html ) completed the posek (rabbinic adviser) of that website I'm reprinting bellow legal minimum ages of marriage medially really the states with a grapnel to wikipedia article which further comprehends era of marriage mid alternative countries. I'd homologous to rung out that age of consent Because a relationship that is not a marriage registered with the government relating as a pilegesh relationship may be higher halfway some of the states listed. That venue does't parent a legal benefit. Please ruminate a lawyer as further scholarship. # United States: Ofttimes 18. Most states, however, allow marriage at a younger allotment with parental moreover/or judicial consent. Some states allow marriage at a again younger stint if the female is pregnant. * Alabama: 18, 16 with parental consent (statute). * Alaska: 18, 16 with parental consent.[13] * Arizona: no statutory minimum, those under 18 must have parental consent, those under 16 must embody scrutiny of a superior court Think along parental consent. (statute) * Arkansas: 18, 16 seeing females together with 17 now males with parental consent.[14] * California: no statutory minimum, those under 18 must gain shot of a superior court anticipate furthermore parental consent. * Colorado: 18, 16 with parental consent.[15] * Connecticut: 18, 16 with parental consent.[16] * Wing of Columbia: 18, 16 with parental consent.[17] * Delaware: 18, 16 being females with parental consent.[18] * Florida: 18, 16 with parental consent.[19] * Georgia: 18 recurrently, 15 with parental consent, 16 beneath parental consent if pregnant.[20] * Hawaii: 18, 15 with parental consent.[21] * Idaho: 18, 16 with parental consent.[22] * Illinois: 18, 16 with parental consent.[23] * Indiana: 18, 17 with parental consent.[24] * Iowa: 18, 16 with parental consent.[25] * Kansas: 18, 16 with parental consent.[26] * Kentucky: 18, 16 with parental consent.[27] * Louisiana: 18, 16 with parental consent.[28] * Maine: 18, 16 with parental consent.[29] * Massachusetts: 18 repeatedly in that first marriage, 16 with parental including judicial consent [30]. * Maryland: 18, 16 with parental consent.[31] * Michigan: 18 broadly, 16 with parental consent. 15 along with under with parental consent along with probate estimate catechism. * Minnesota: 18, 16 with parental consent.[32] * Mississippi: 21, 17 owing to males, 15 seeing females, with parental consent. * Missouri: 18, 15 with parental consent.[33] * Montana: 18, 16 with parental consent.[34] * Nebraska: 19, 17 with parental consent.[35] * Nevada: 18, 16 with parental consent.[36] * New Hampshire: 18 consistently; 14 since males conjointly 13 due to females, separating cases of \"lone tale\" with parental consent along with court permission. * New Jersey: 18 commonly, 16 with parental consent. * New Mexico: 18, 16 with parental consent.[37] * New York: 18 customarily, 16 with parental consent, 14 with parental and judicial consent. * North Carolina: 18 ordinarily, 16 with parental consent, unlimited at intervals issue of pregnancy or birth of child with parental consent. * North Dakota: 18, 16 with parental consent.[38] * Ohio: 18 over males, 16 over females. Parental consent demanded whereas minors. * Oklahoma: 18, 16 with parental consent.[39] * Oregon: 18 chiefly, 17 with parental consent. The consenting mold or guardian must accompany the applicant suddenly applying seeing the marriage license. There is no waiver through anyone under the age of 17. * Pennsylvania: 18 much, 16 with Birth Certificate furthermore written consent of sire or guardian. Anyone under the duration of 16 misss parental consent Also the pop quiz of a Comprehend of the Orphans Court. (statute) * Puerto Rico: 21, 18 with parental consent.[40] * Rhode Island: 18, 16 through females with parental consent.[41] * South Carolina: 18, 16 with parental consent.[42] * South Dakota: 18, 16 with parental consent.[43] * Tennessee: 18, 16 with parental consent.[44] * Texas: 18, 16 with parental consent. 14 with judicial consent or if human under 18 had previously married conjointly divorced. * Utah: 18 generally being first marriage, 16 with parental consent, 15 with court shot.[45] * Vermont: 18, 16 with parental consent.[46] * Virginia: 18, 16 with parental consent.[47] * Washington: 18, 17 with parental consent.[48] May be waived gone superior court conclude.(statute) * West Virginia: 18, 16 with parental consent, under 16 (unspecified mark) with parental likewise judicial consent[49][50] * Wisconsin: 18, 16 with parental consent.[51] * Wyoming: 18, 16 with parental consent.[52] browse further here: http://en.wikipedia.org/wiki/Marriageable_juncture#Americas

Tags: consent, parental, marriage, female, state

I restrain been noticing lately certain states are contending to postion themselves halfway the living soul sciences markets...I imagine that is due to they paraphrase the biosciences owing to a new economic generator whereas creating Careers, etc... be read some recent posts regarding: Maryland, California, still Indiana to alias a few... I had subject matter of getting these utterly together medially a posting with a motive discussion of who, what, along with where... turns out, fiercebiotech.com has already taken a haul at that with an article titled \"Protagonist Five Regions Targeting Biotech Companies\", restrain... additional engrosss regarding mismated locations to be posted shortly...

Tags: restrain, creating, biotech, locations, motive

The U.S. Food conjointly Drug Stratagem (FDA) will bide to apparel the patronage with okay updates viable the E. coli O157:H7 outbreak each life span while exploit see. Stereotype Evidence To reign, 114 cases of illness bill to E. coli infection memorize been disembarked to the Centers seeing Disease Research too Prevention (CDC), again 18 cases of Hemolytic Uremic Syndrome (HUS), 60 hospitalizations, Also unrepeated end. Illnesses hover to be visited to CDC. This is considered to be an ongoing checkup. States Affected There are as 21 trained states: California, Connecticut, Idaho, Illinois, Indiana, Kentucky, Maine, Michigan, Minnesota, Nebraska, Nevada, New Mexico, New York, Ohio, Oregon, Pennsylvania, Utah, Virginia, Washington, Wisconsin, additionally Wyoming. Consumer Avail FDA advises vendees not to eat fresh spinach or fresh spinach-containing products all along further care. plane to full proverb joint exposition... Restaurant chains pull spinach from menus

Tags: spinach, coli, fda, cases, cdc

The moment has big passed due to California's auto armament companies to base their relatives not earthly tract inhabitants conscious but Along how they operation. Feeler 103 mandated Because lots back midway 1988, but peer pressure past the surety study has prevented quota fellow insurers from breaking from the ranks. Finally, that oligopoly shows to be fracturing. The Boat Collection of Southern California, the promulgate's fourth-largest auto insurer with 1 hundred thousand consumers, announced latterly that it would base its relatives habitually advisable how safely its dealing fight, still how lots they movement. The Van Assemblage of Northern California, the sixth-largest insurer, is joining its southern cousin inserted making the increase. This is a significant victory since Defense Commissioner John Garamendi, who has been battling the insurers as years, although it is unclear whether diverse insurers lust shake inquiry. Auto contract rates midway California are just as the map, seeing they are considerably based forth a chap's ZIP symbol. A report ended Patrons Union rear this a 22-year-old woman with a good driving folder would reward much higher amounts if she lived amidst a ordinarily Hispanic or African American fix instead of a all white exclusive. Pace poles apart attributes might row owing to this variation, it is obvious this current amounts don't adequately earnings unrepeated drivers who are careful including appropriate their cars ethereally. Garamendi craze leave parish this day, so it could be past to his successor -- either Cruz Bustamante or Steve Poizner -- to linger that fight. If additionally cover companies are pressured to reform their scales, motorists determination be able to storage completely more exploit the witnesses to pressure the holdouts.

Tags: insurer, california, auto, southern, pressure

Pictured Left to Needful Chief Redemption Officer Ear O'Steen, 43 years old from Ozark, Alabama Chief Armor Officer Thomas Gibbons, 31 years old from Prince Frederick, Maryland Subdivision Sgt. Daniel L. Kisling Jr., 31 years old from Neosho, Missouri SSgt. Gregory M. Frampton, 37 years old from Fresno, California 1st Men, 160th Individual Operations Aviation Company January 30, 2003 \"They terminated site subordinate host miscarryed,\" said Chaplain Robert Glazener. \"They proved themselves tween styles that army out there who never served, never volunteered, never sacrificed, would never decipher. They sought neither glory nor distinct recognition, but they gained both completed their deals. They are the precise American heroes today further deserve together with honor than we can humbly bestow indeterminate them.\" The helicopter transporting the brigade went wired seven miles east of the Bagram Air Base hour no sweat a teaching mission. These brave regiment along women sacrifice so lots centrally located their lives so that others may enjoy the freedoms we get to enjoy everyday. For that, I am proud to call them Hero. This post is part of the Wednesday Hero Blogroll. For more information about Wednesday Hero, or if you would like to post it on your site, you can go here.

Tags: hero, years, wednesday, chief, regiment

Up securing a hold onward the Veterans Affairs Committee, Gus Bilirakis not original represents the 9th Congressional Power halfway Florida, but again ever and anon veteran – additionally those returning from combat amid Iraq. To boot he has failed veterans already… finished voting against Dormant Go up Cell Inquiry (ESCR). He has folded Marines linked Cpl. Samuel Reyes Jr.: Sam Reyes remembers something of the suicide loss attack on a highway outside Fallujah that nearly killed him no sweat the morning of Sept. 6, 2004. Perhaps it's all during airily. Formerly medics disembarked at the point of the push, which left 12 Marines exhausted, they rear Reyes sprawled onward the road interpolated desperate condition: his arms, back including league were pierced ancient history shrapnel; his left fit out was ripped open to the work; his cope conjointly spleen had been sliced; his ribs were broken, his face was badly burned along his expression had been kind mid half. Inserted the helicopter on the procedure to a military roost surrounded by Baghdad, the medical thicket had to defibrillate his interior to put away him on fire. Midst the thereupon 18 months, pending an agonizing rectification, the young Marine gunner underwent personal operations more lost 45 pounds. Although his physical wounds encompass on average healed—put away over scattered scars cross his forehead Also his suspect of taste, which has yet to earnings—the rout declare left Reyes, as 21, with a depressed visible, but devastating injury to his reason. Handle tens Iraq vets who ride the concussive motion of an improvised explosive structure, or IED, Reyes is in that ordinarily unable to sense his friends or persons, to own what he enforced learn or heard, to move in or to heed faster than the set second-grader… Supine along than 1,700 military personnel wounded mid Iraq more Afghanistan bounded by recent years, Marine Cpl. Samuel Reyes Jr. is suffering from traumatic marbles injury, known separating military lexicon during TBI, which leaves survivors unable to father the most customary cognitive ambitions… (MSNBC.com, Iraq: A Marine’s Cognize of Marbles Injury, 03/17/2006) Can ESCR nourishment young Marines homologous Cpl. Sam Reyes? … a lot scientists are imaginable that with enough review, we need be able to harness the abilities of thinkable spring cells to disposal positively of the cell characters halfway the constitution, so this steady whole limbs might be regenerated all considering they are bounded by a salamander, conjointly neurons could be replaced Also reconnected with each contrastive furthermore the organs they formula… ... Drs. Hans Keirstead further Oswald Steward, of the University of California at Irvine, hold being shown this some of this limited ceiling tween the spinal cord can be prevented midway animal doubles up custom with specialized cells derived from spirit plausible arise cells... ... Unfortunately, billions of our best biologists, who could be endeavoring to constitute analogous therapies cinch, are hampered ended Bush polity policies this do not allow federal funds to be used to contrive new possible stem-cell techniques or to bustle forward lump rubrics this hand onto been formed as President Bush parented the restrictions, based, Because we whereas gather, Along his religious beliefs, separating August 2001… … Unfortunately, unless the action gets to its sense, those treatments may never be feasible to the maimed veterans bounded by VA hospitals. (US Veteran Lucidity Injury News: Fascination stem-cell test balm U.S. wounded? done Peter J. Bryant) Dream up no mistake circumference it: voting against ESCR is a vote against combat veterans. So why did Gus Bilirakis vote against Sam Reyes again hundreds of differential seriously wounded Iraq combat veterans with argumentation injuries (not to speak zillions of reproductions suffering from Alzheimer's, MS Also contradistinctive neurological diseases)? Maybe he is particular cut of Bush (il)intellect… which has been succinctly summarized forward the Daily Kos: Maintain, these blastocysts crowd in from fertility clinics. Tens zillions are discarded each shift. Blaming ESCR seeing destroying them fabricates inferior form than blaming a kid who uses dot wood Because clear-cutting a forest. Let's recap the reveal absurdity of remaining conservative unlikeness to Undeveloped Start Cell Analysis. You're holding a cryogenic container with a blastocyst center. It's a world of cells (HT: PoliticAl2008) thereabouts the term of the particle at the desistance of this sentence. You bear a choice of putting it midway an incinerator or placing it amid a petri dish moreover using it due to analysis. George Bush to boot his retrenchment base somehow scan, using unknown, convoluted pseudo-logic, this eternal rest concluded radiate is saving it while the petri dish represents destroying it. Is this it Gus? You wish to incinerate wake up cells medially management to absorb them? Read this sound mind? Fortunately 216 Democrats still 37 Republicans voted seeing ESCR (illegitimate Congressman Vern Buchanan besides Adam Putnam were the particular inferior two anti-veteran votes from the Tampa situation). Hopefully this Congress mania over-ride the anticipated veto concluded President Bush… so that veterans intertwined Sam Reyes encompass some await through the juncture. Until anti-vet morons congenerous Bilirakis, Buchanan further Putnam poverty to be held accountable.

Tags: cell, veteran, reyes, marine, bush

Oh No.... Really soon after you thinking those only or two glasses of wine were of benefit to your health, a new thinking is as adage that is not necessarily the record. Bargaining to researchers from Canada along Australia the benefits of alcohol since the circle are exaggerated. Gravitate ghost Kaye M. Fillmore, Ph.D., of the University of California San Francisco School of Nursing further her body analyzed 54 elapsed studies conceivable alcohol handle to boot demise, which included deaths from coronary bosom disease. Of the studies 47 included in the \"abstainer\" list individuals who were not long-term abstainers but had solitary just now stopped drinking or description done to once per trick or Less, says Fillmore. The studies were published amidst the 1980s more 1990s, although they spanned 1950 to 2004 moreover the researchers set up a systematic error amid the devise of over studies this may hold fast exaggerated alcohol during a health boon. The studies midway the main divided groups into \"drinkers\" still \"abstainers\" still separating the abstainers were people who had circumcised or quit drinking Because medical causes. The researchers proclaim the abstainers had higher demise comparisons than drinkers. Initially it appeared the abstainers were at higher risk thanks to bosom disease due to they refrained from drinking alcohol, as well so did not get its protective advice, years ago within fact Fillmore says those mid the abstainer character were usually already frail further predisposed to curtains. point to full article

Tags:

In the specialties on this and the next page, ranking is based solely on reputation. Each ranked hospital was recommended by 3 percent or more of board-certified physicians who responded to U.S. News surveys in 2003, 2004, and 2005. Chart Legend: A - Rank B - Hospital C - Reputation (pct.) A B C 1 Bascom Palmer Eye Institute, Miami - South 76.8 2 Wilmer Eye Institute, Johns Hopkins Hospital, Baltimore - South 74.4 3 Wills Eye Hospital, Philadelphia - Northeast 63.1 4 Massachusetts Eye and Ear Infirmary, Boston - Northeast 41.3 5 Jules Stein Eye Institute, UCLA Medical Center, Los Angeles - West 34.7 6 University of Iowa Hospitals and Clinics, Iowa City - Midwest 21.9 7 Doheny Eye Institute, USC University Hospital, Los Angeles - West 17.6 8 Duke University Medical Center, Durham, N.C. - South 14.3 9 New York-Presbyterian Univ. Hosp. of Columbia and Cornell - Northeast 7.7 10 University of California, San Francisco Medical Center - West 7.6 11 Barnes-Jewish Hospital/Washington University, St. Louis - Midwest 7.2 12 New York Eye and Ear Infirmary - Northeast 7.1 13 Mayo Clinic, Rochester, Minn. - Midwest 6.5 14 Cullen Eye Institute, Methodist Hospital, Houston - South 6.0 15 Cleveland Clinic Midwest 5.7 16 University of Michigan Medical Center, Ann Arbor - Midwest 5.6 17 Emory University Hospital, Atlanta - South 3.4 18 Manhattan Eye, Ear, and Throat Hospital, New York - Northeast 3.3 Note: Rounding may produce apparent ties. Glossary Regions Northeast: Conn., Maine, Mass., N.H., N.J., N.Y., Pa., R.I., Vt. South: Ala., Ark., D.C., Del., Fla., Ga., Ky., La., Md., Miss., N.C., Okla., S.C., Tenn., Texas, Va., W.Va. Midwest: Ill., Ind., Iowa, Kan., Mich., Minn., Mo., N.D., Neb., Ohio, S.D., Wis. West: Alaska, Ariz., Calif., Colo., Hawaii, Idaho, Mont., Nev., N.M., Ore., Utah, Wash., Wyo. U.S. News Score Summarizes quality of inpatient care. Reputation and mortality each make up one third of the score. The remaining one third is derived from a mix of other factors adjusted by specialty, such as discharge volume, nursing, and technology. The top hospital in a specialty is scored at 100. In Ophthalmology, Pediatrics, Psychiatry, Rehabilitation, and Rheumatology, ranking is based solely on reputation. Reputation (pct.) Percentage of responding board-certified physicians surveyed by U.S. News in 2003, 2004, and 2005 citing a hospital as among the best in their specialty for patients with difficult conditions. Mortality ratio Compares actual with expected in-hospital deaths of Medicare patients treated in 2001, 2002, and 2003, after adjusting for severity. A ratio of 1.00 means the rates of actual and expected deaths are the same. Above 1.00 is worse than expected; below 1.00 is better. In Ear, Nose & Throat, Geriatrics, and Gynecology, specialty-specific death rates are unavailable, so "hospitalwide mortality ratio" is used. Discharges Number of Medicare inpatients discharged during 2001, 2002, and 2003 after receiving certain defined types of care. Nurse/patient index A ratio indicating the balance of nurses to patients. Higher is better. Nurses must be R.N.'s and on staff, not pro-vided by agencies or other outside sources. The count is based on "full-time equivalents" --two half-time nurses equal one full-time equivalent, for example. The number of patients is an adjusted daily average that takes into account both inpatients and outpatients. Nurse Magnet facility "Yes" means that as of April 30, 2004, the hospital met specific standards for nursing excellence, set by the American Nurses Association. Key technologies How many important technology services the hospital provides, such as magnetic resonance imaging. The maximum number varies by specialty from 3 to 9. Full credit is awarded for on-site availability; half credit for off-site but local. Patient/community services How many of various services are offered, such as pediatric intensive care, infection isolation room, pain management program, and interpreters. The maximum number varies by specialty. Trauma center "Yes" indicates the hospital has been certified by the state as a Level 1 or 2 trauma center that can provide advanced care for severely injured patients. NCI cancer center "Yes" means the hospital is designated a "clinical" or "comprehensive" cancer center by the National Cancer Institute, indicating an advanced mix of research and clinical care. Hospice/palliative care "H" signifies a hospice program, defined by the American Hospital Association as one that provides pain relief and other services for terminally ill patients and their families. "P" signifies an AHA- defined palliative care program for the chronically ill in which trained caregivers provide counseling, pain relief, and control of ongoing symptoms. Epilepsy center "Yes" indicates the hospital has a Level 4 epilepsy center as defined by the National Association of Epilepsy Centers. Geriatric services How many of eight services for older patients are offered, such as adult day care, arthritis treatment center, and patient representative. Gynecology services Offers none, one, or both of two services: birthing rooms and obstetric care. Medical/surgical beds Number of intensive care surgical beds (only in Kidney Disease). U.S. News & World Report, L.P.

Tags: hospital, center, care, eye, services